NCT04569448View on ClinicalTrials.gov

Brexpiprazole Treatment for Bipolar I Depression

PHASE3RecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Bipolar Depression
Interventions
DRUG

Brexpiprazole

Adjunctive variable dose (1-3 mg/day) Brexpiprazole

Trial Locations (3)

L8S 4L8

TERMINATED

McMaster University, Hamilton

H3T 1E2

WITHDRAWN

Jewish General Hospital, Montreal

H4H 1R3

RECRUITING

Douglas Mental Health University Institute, Montreal

All Listed Sponsors
collaborator

McMaster University

OTHER

collaborator

Jewish General Hospital

OTHER

lead

Douglas Mental Health University Institute

OTHER